Metformin to Reduce Heart Failure After Myocardial Infarction
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The investigators will evaluate the effect of metformin therapy during 4 months in
non-diabetic patients following ST-elevation myocardial infarction on left ventricular
ejection fraction as measured with cardiac magnetic resonance imaging, compared to placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Medical Center Groningen
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development